Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.150
0.00 (0.00%)
At close: Feb 27, 2026, 4:00 PM EST
1.149
-0.001 (-0.11%)
After-hours: Feb 27, 2026, 6:40 PM EST
Enlivex Market Cap
Enlivex has a market cap or net worth of $272.99 million as of February 27, 2026. Its market cap has increased by 1,082.33% in one year.
Market Cap
272.99M
Enterprise Value
255.49M
1-Year Change
1,082.33%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has increased from $101.63M to $272.99M, an increase of 168.61%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 272.99M | 63.54% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 280.01M |
| Aardvark Therapeutics | 277.17M |
| Minerva Neurosciences | 272.41M |
| C4 Therapeutics | 271.84M |
| Shattuck Labs | 265.78M |
| Alector | 260.33M |
| OmniAb | 257.68M |
| Prelude Therapeutics | 256.26M |